Company · CIK 0001127537 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
Pulmonx Corp · LUNG
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 3, 6:23 pm EDT | Glendon E. French IIIPresident and CEO, Director | 41,882 | $2.26 | $94,653 | 1,137,936 | −3.55% | |
| Sep 1, 2026 SForm 4 → | Sep 3, 6:21 pm EDT | Srikanth RadhakrishnanChief Science & Techn. Officer | 14,245 | $2.26 | $32,194 | 316,994 | −4.30% | |
| Sep 1, 2026 SForm 4 → | Sep 3, 6:19 pm EDT | David Aaron LehmanGeneral Counsel | 14,334 | $2.26 | $32,395 | 361,827 | −3.81% | |
| Sep 1, 2026 SForm 4 → | Sep 3, 6:17 pm EDT | Geoffrey Beran RoseChief Commercial Officer | 7,879 | $2.26 | $17,807 | 449,832 | −1.72% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.